Skip to main content

CDT Equity Inc. (CDTTW)

New York Stock Exchange Healthcare BiotechnologyView data quality →
63.5Fair

ValueMarkers Composite Index

Top 90%#4,532 of 44,722
Undervalued

100% below intrinsic value ($1,898,649)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-
Altman
1.87
Grey Zone
DCF Value
$1,898,649
Undervalued
ROIC
9.9%
Adequate
P/E
0.0
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

CDT Equity Inc. (CDTTW) — VMCI valuation read

CDT Equity Inc. (CDTTW) carries a VMCI composite of 64/100, 14 points above the Healthcare sector median of 50. Among mid-cap names, that gap places CDTTW in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The CDTTW insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads CDTTW trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of -1.3x leaves covenant headroom, the line to track on CDT Equity Inc.'s next 10-Q.

CDTTW fell 2.2% over the trailing 7 days, with a -11.8% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.